Norges Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-859,389
| Closed | -$15.5M | – | 2187 |
|
|
2020
Q2 | $15.5M | Buy |
859,389
+390,206
| +83% | +$5.43M | ﹤0.01% | 1579 |
|
|
2020
Q1 | $3.35M | Sell |
469,183
-164,233
| -26% | -$2.05M | ﹤0.01% | 1878 |
|
|
2019
Q4 | $15.1M | Buy |
633,416
+38,828
| +7% | +$1.07M | ﹤0.01% | 1669 |
|
|
2019
Q3 | $15.9M | Buy |
594,588
+40,000
| +7% | +$1.12M | ﹤0.01% | 1600 |
|
|
2019
Q2 | $15M | Sell |
554,588
-32,765
| -6% | -$1.03M | ﹤0.01% | 1643 |
|
|
2019
Q1 | $20.4M | Hold |
587,353
| – | – | 0.01% | 1493 |
|
|
2018
Q4 | $11.5M | Hold |
587,353
| – | – | ﹤0.01% | 1681 |
|
|
2018
Q3 | $15.6M | Buy |
587,353
+36,832
| +7% | +$1.2M | 0.01% | 1646 |
|
|
2018
Q2 | $20.8M | Sell |
550,521
-210,586
| -28% | -$8.05M | 0.01% | 1499 |
|
|
2018
Q1 | $24.9M | Buy |
761,107
+66,570
| +10% | +$2.92M | 0.01% | 1283 |
|
|
2017
Q4 | $33.8M | Hold |
694,537
| – | – | 0.01% | 1080 |
|
|
2017
Q3 | $37.5M | Buy |
694,537
+81,485
| +13% | +$4.78M | 0.01% | 974 |
|
|
2017
Q2 | $34.4M | Buy |
613,052
+177,105
| +41% | +$7.09M | 0.01% | 1016 |
|
|
2017
Q1 | $17.1M | Sell |
435,947
-11,734
| -3% | -$374K | 0.01% | 1486 |
|
|
2016
Q4 | $10M | Hold |
447,681
| – | – | ﹤0.01% | 1682 |
|
|
2016
Q3 | $9.71M | Buy |
447,681
+53,562
| +14% | +$1.26M | ﹤0.01% | 1659 |
|
|
2016
Q2 | $9.3M | Hold |
394,119
| – | – | ﹤0.01% | 1652 |
|
|
2016
Q1 | $8.04M | Sell |
394,119
-76,787
| -16% | -$2.44M | ﹤0.01% | 1668 |
|
|
2015
Q4 | $24.2M | Buy |
470,906
+49,806
| +12% | +$2.41M | 0.01% | 1043 |
|
|
2015
Q3 | $17.9M | Buy |
421,100
+285,966
| +212% | +$13.8M | 0.01% | 1193 |
|
|
2015
Q2 | $6.16M | Buy |
135,134
+29,413
| +28% | +$1.18M | ﹤0.01% | 1842 |
|
|
2015
Q1 | $4.01M | Buy |
+105,721
| New | +$3.63M | ﹤0.01% | 1949 |
|
|
2014
Q2 | – | Sell |
-92,358
| Closed | -$2.39M | – | 2258 |
|
|
2014
Q1 | $2.39M | Hold |
92,358
| – | – | ﹤0.01% | 2018 |
|
|
2013
Q4 | $2.38M | Hold |
92,358
| – | – | ﹤0.01% | 2018 |
|
|
2013
Q3 | $2.47M | Buy |
+92,358
| New | +$2.2M | ﹤0.01% | 2033 |
|
Norges Bank's PTLA Position: Q3 2020 in Review
Norges Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 859,389 shares — an estimated $15.5M sold.
Norges Bank first reported a position in PTLA in Q3 2013 and held it in 25 quarters. The position peaked at $37.5M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Norges Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Norges Bank sold 859,389 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $15.5M.
- Norges Bank first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 25 quarters.
- Norges Bank's Portola Pharmaceuticals, Inc. position peaked at $37.5M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Norges Bank's 13F filing for Q3 2020, filed 10 Nov 2020.